Grantham, Mayo, Van Otterloo & Co (GMO)’s Enact Holdings ACT Stock Holding History
Bought
Maintained
Sold
Other funds holding ACT
VPM
GCM
VCM
Grantham, Mayo, Van Otterloo & Co (GMO)'s ACT Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Enact Holdings (ACT) in Q1 2026, closing a stake of 10,490 shares — an estimated $416K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACT in Q2 2024 and held it in 7 quarters. The position peaked at $754K in Q2 2025. 251 funds tracked by Wall St. Rank hold ACT as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Enact Holdings position as of Q1 2026 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,490 Enact Holdings shares in Q1 2026, an estimated $416K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Enact Holdings in Q2 2024 and held it in 7 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Enact Holdings position peaked at $754K in Q2 2025.
- 251 funds tracked by Wall St. Rank held Enact Holdings as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.